← Leaderboards
Christopher J Destache
Creighton University
$2,806,487
Attributed
$2,806,487
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $556.5K · FY2008–18$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,806,487 · 3
By mechanism
R01$2,092,312 · 1
R56$410,913 · 1
R15$303,262 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Delivery Systems”
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Gerald Van Belle · University Of Washington$48,120,734
- David Heimbrook · Leidos Biomedical Research, Inc.$47,325,954
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$38,382,452
- Martin Friedlander · Scripps Research Institute$36,319,942
Research focus
Drug Delivery SystemsAnti-Retroviral AgentsHiv-1Pharmaceutical PreparationsNanoparticleBaseDoseDrug KineticsReportingIn VivoAdverse EffectsDrug UsageIn VitroCell Culture SystemDrug CombinationsTissuesReconstitutionRouteDesignModalityMouse ModelAwardIntentionInfection
Grant awards (7)
Long-acting antiretroviral nanoparticles for HIV prophylaxis$544,860
R01 · FY2018 · AI · contact PI
Long-acting antiretroviral nanoparticles for HIV prophylaxis$543,485
R01 · FY2017 · AI · contact PI
Long-acting antiretroviral nanoparticles for HIV prophylaxis$556,546
R01 · FY2016 · AI · contact PI
Long-acting antiretroviral nanoparticles for HIV prophylaxis$447,421
R01 · FY2015 · AI · contact PI
Once Monthly Antiretroviral Nanoparticles for HIV-1 Treatment$410,913
R56 · FY2011 · AI · contact PI
Pharmacology of Antiretroviral Nanoparticle Micelles$78,589
R15 · FY2010 · AI · contact PI
Pharmacology of Antiretroviral Nanoparticle Micelles$224,673
R15 · FY2008 · AI · contact PI